Homologous recombination deficiency in PD-L1, PD-L2, Jak2 (PDJ) amplified triple negative breast carcinoma

被引：0
|
作者：
Gawryletz, C. D.
Anderson, K. S.
Northfelt, D. W.
Kosiorek, H. E.
Linnaus, M. E.
Ocal, I. T.
McCullough, A. E.
Pockaj, B. A.
Barrett, M. T.
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Arizona State Univ, Ctr Personalized Diagnost, Biodesign Inst, Tempe, AZ USA
[3] Mayo Clin, Scottsdale, AZ USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P1-05-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-05-19
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Comprehensive assessment of PD-L1 and PD-L2 dysregulation in gastrointestinal cancers
    Zhao, Qijie
    Guo, Jinan
    Zhao, Yueshui
    Shen, Jing
    Kaboli, Parham Jabbarzadeh
    Xiang, Shixin
    Du, Fukuan
    Wu, Xu
    Li, Mingxing
    Wan, Lin
    Li, Xiang
    Wen, Qinglian
    Li, Jing
    Zou, Chang
    Xiao, Zhangang
    EPIGENOMICS, 2020, 12 (24) : 2155 - 2171
  • [32] Clinical relevance of PD-L1 and PD-L2 overexpression in patients with esophageal squamous cell carcinoma
    Hsieh, Chih-Cheng
    Hsu, Han-Shui
    Li, Anna Fen-Yau
    Chen, Yann-Jang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4433 - 4444
  • [33] PD-L1 testing in triple negative breast cancer
    Dobritoiu, F.
    Chefani, A.
    Billingham, K.
    Chenard, M.
    Vaziri, R.
    Lacroix-Triki, M.
    Waydelich, A.
    Erb, G.
    Toro, P.
    Wedden, S.
    D'Arrigo, C.
    VIRCHOWS ARCHIV, 2019, 475 : S17 - S18
  • [34] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
    Jeong, Seri
    Lee, Nuri
    Park, Min-Jeong
    Jeon, Kibum
    Song, Wonkeun
    CANCERS, 2021, 13 (20)
  • [35] Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors
    Pinto, Navin
    Park, Julie R.
    Murphy, Erin
    Yearley, Jennifer
    McClanahan, Terri
    Annamalai, Lakshmanan
    Hawkins, Douglas S.
    Rudzinski, Erin R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [36] Expression of PD-L1, PD-L2 and PD-1 in thymic epithelial tumours (TETs).
    Gennatas, Spyridon
    Fernandez, Angeles Montero
    Bowman, Alex
    Ronquillo, John
    Nicholson, Andrew G.
    Popat, Sanjay
    Bowcock, Anne
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Association of PD-1, PD-L1 and PD-L2 expression with clinicopathological factors in tongue squamous cell carcinoma
    Tsuchihashi, Kei
    Nakatsugawa, Munehide
    Asanuma, Hiroko
    Miyazaki, Akihiro
    Torigoe, Toshihiko
    CANCER SCIENCE, 2018, 109 : 498 - 498
  • [38] PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinoma
    de Vos, Luka
    Dietrich, Joern
    Strieth, Sebastian
    Bootz, Friedrich
    Dietrich, Dimo
    Franzen, Alina
    IMMUNOTHERAPY, 2020, 12 (12) : 903 - 920
  • [39] Expression of PD-1, PD-L1, and PD-L2 in the liver in autoirnmune liver diseases
    Mataki, Norikazu
    Kikuchi, Kentaro
    Kawai, Toshihiro
    Higashiyama, Masaaki
    Okada, Yoshikiyo
    Kurihara, Chle
    Hokari, Ryota
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Kondo, Toshiro
    Itoh, Kazuro
    Miyakawa, Hiroshi
    Miura, Soichiro
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (02): : 302 - 312
  • [40] Epigenetic Regulation of PDCD1 (PD-1), PD-L1 (CD274) and PD-L2 (PDCD1LG2) as Biomarkers in the Immunotherapy of triple negative Breast Cancer
    Ralser, D. J.
    Kluemper, N.
    Kaiser, C.
    Faridi, A.
    Abramian, A.
    Dietrich, D.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E104 - E105
12345